Bernhard Maisch

Q: What Schools Are Affiliated With Bernhard Maisch

Bernhard Maisch is affiliated with the following schools: University of Marburg, Hannover Medical School

Bernhard Maisch's AcademicInfluence.com Rankings

Bernhard Maisch

Medical

#1777

World Rank

#2153

Historical Rank

Cardiology

#143

World Rank

#146

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Bernhard Maisch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernhard Maisch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. (1996) (3213)
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. (2007) (2426)
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2013) (2213)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. (2004) (1199)
Safety of Transesophageal Echocardiography: A Multicenter Survey of 10,419 Examinations (1991) (745)
High bone density due to a mutation in LDL-receptor-related protein 5. (2002) (675)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
Increased osteoprotegerin serum levels in men with coronary artery disease. (2003) (351)
Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Results of the Marburg Cardiomyopathy Study (2003) (332)
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. (2015) (294)
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. (2011) (293)
Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2014) (263)
Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 (2004) (250)
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). (1997) (212)
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. (2004) (212)
[Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. (2004) (207)
Diabetic cardiomyopathy—fact or fiction? (2011) (202)
Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. (1983) (200)
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) First Epidemiological Results (2000) (197)
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. (2006) (193)
Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. (2006) (176)
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. (1982) (175)
Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. (2002) (169)
Definition of Inflammatory Cardiomyopathy (Myocarditis): On the Way to Consensus A Status Report (2000) (163)
Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. (1984) (160)
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. (2015) (156)
Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. (2003) (151)
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). (1995) (147)
Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. (1998) (139)
Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. (1996) (129)
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. (2014) (126)
Inflammatory Dilated Cardiomyopathy (DCMI) (2005) (123)
Evaluation and management of pericardial effusion in patients with neoplastic disease. (2010) (122)
Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. (2006) (120)
Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease. (1999) (119)
Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. (2000) (118)
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction (2011) (115)
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. (2002) (113)
Genetic Association Study Identifies HSPB7 as a Risk Gene for Idiopathic Dilated Cardiomyopathy (2010) (110)
Practical aspects of the management of pericardial disease (2003) (110)
Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. (1995) (105)
Osteoprotegerin gene polymorphisms in men with coronary artery disease. (2004) (105)
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. (2002) (101)
The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. (1995) (101)
Guidelines on the Diagnosis and Management of Pericardial Diseases (2004) (99)
Hormonal regulation of cardiac fibroblast function. (1995) (98)
The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure (2002) (96)
Myocardial collagen matrix remodelling in arterial hypertension. (1992) (95)
Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. (1994) (93)
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. (1979) (92)
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)]. (2015) (91)
Prognostic Significance of Heart Rate Turbulence Following Ventricular Premature Beats in Patients with Idiopathic Dilated Cardiomyopathy (2003) (86)
Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. (2005) (86)
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. (2002) (86)
Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. (1993) (86)
Bacterial Pericarditis (2005) (82)
Cytomegalovirus associated inflammatory heart muscle disease. (1993) (82)
Pericardial syndromes: an update after the ESC guidelines 2004 (2013) (81)
Immune response to the endothelium in myocarditis, dilated cardiomyopathy and rejection after heart transplantation. (1991) (78)
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure (2011) (78)
Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. (1993) (77)
Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. (1997) (77)
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. (2008) (76)
Treatment of Inflammatory Dilated Cardiomyopathy and (Peri)Myocarditis with Immunosuppression and i.v. Immunoglobulins (2004) (76)
Pathophysiology of viral myocarditis: the role of humoral immune response. (2002) (76)
Athlete’s heart or hypertrophic cardiomyopathy? (2009) (75)
Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy. (1995) (75)
Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. (1997) (74)
Cardiotoxicity of 5-fluorouracil. (2006) (73)
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy (2008) (73)
QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. (1996) (72)
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy (2012) (71)
Incidence rates and predictors of major and minor depression in patients with heart failure. (2013) (70)
Coxsackievirus B3 infection leads to cell death of cardiac myocytes. (1994) (69)
Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. (1997) (69)
MR, CT, and PET imaging in pericardial disease (2013) (69)
The classification of pericardial disease in the age of modern medicine (2002) (66)
Pericardioscopy and epi- and pericardial biopsy—a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy (2013) (65)
Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. (1997) (65)
Management Strategies in Pericardial Emergencies (2006) (65)
Cytokine Activation in Pericardial Fluids in Different Forms of Pericarditis (2000) (65)
Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. (2013) (65)
Prevalence of Viral Genome in Endomyocardial Biopsies from Patients with Inflammatory Heart Muscle Disease (2000) (64)
Ventricular remodeling. (1996) (64)
Cytomegalovirus-associated heart muscle disease. (1995) (64)
Risk Stratification by the “EPA+DHA Level” and the “EPA/AA Ratio” (2004) (62)
Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. (1982) (60)
B-type natriuretic peptide and wall stress in dilated human heart (2008) (59)
Clinical and immunologic characteristics in peripartum cardiomyopathy. (2007) (58)
Pericardioscopy and epicardial biopsy--new diagnostic tools in pericardial and perimyocardial disease. (1994) (58)
Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation (2004) (56)
Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. (2007) (56)
Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. (1997) (56)
Treatment options in myocarditis and inflammatory cardiomyopathy (2018) (55)
Pericardial diseases, with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods, and treatment. (1994) (55)
Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. (1995) (54)
Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options (2019) (54)
Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. (2004) (54)
Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography. (2000) (52)
Human viral cardiomyopathy. (2003) (51)
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. (2012) (51)
Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy—results from a pilot study (1999) (50)
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non‐ischaemic dilated cardiomyopathy (2011) (50)
Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options (2014) (49)
Recurrent pericarditis: mysterious or not so mysterious? (2005) (48)
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. (2003) (48)
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives (2013) (47)
Alcohol and the Heart (2001) (47)
Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Design and First Results of the Marburg Cardiomyopathy Study (1998) (46)
Alcoholic cardiomyopathy (2016) (46)
Pericardial effusion of HIV-infected patients - results of a prospective multicenter cohort study in the era of antiretroviral therapy (2011) (46)
A new methodological approach to assess cardiac work by pressure–volume and stress–length relations in patients with aortic valve stenosis and dilated cardiomyopathy (2007) (46)
Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term (2018) (45)
Pericardial Disease in Pregnancy (2003) (45)
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis (2013) (45)
Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy (2004) (44)
Effects of ACE Inhibition versus Non-ACE Inhibitor Antihypertensive Treatment on Myocardial Fibrosis in Patients with Arterial Hypertension (2003) (44)
A network against failing hearts--introducing the German "Competence Network Heart Failure". (2010) (43)
Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion (2013) (43)
Cardiomyopathies: classification, diagnosis, and treatment. (2012) (43)
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. (1993) (43)
Osteoprotegerin expression in dendritic cells increases with maturation and is NF‐κB‐dependent (2007) (43)
Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. (2006) (42)
Inflammation in Dilated Cardiomyopathy (2004) (41)
Long Runs of Non‐Sustained Ventricular Tachycardia on 24‐Hour Ambulatory Electrocardiogram Predict Major Arrhythmic Events in Patients with Idiopathic Dilated Cardiomyopathy (2005) (41)
Heart Rate Turbulence following Ventricular Premature Beats in Healthy Controls (2003) (41)
A new but frequent mutation of apoB-100-apoB His3543Tyr. (2004) (41)
Influence of D‐Net (European GSM‐Standard) Cellular Phones on Pacemaker Function in 50 Patients with Permanent Pacemakers (1996) (41)
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. (2006) (40)
Interventional Pericardiology: Pericardiocentesis, Pericardioscopy, Pericardial Biopsy, Balloon Pericardiotomy, and Intrapericardial Therapy (2011) (40)
Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. (2001) (40)
Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions (2013) (40)
Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients with Prophylactic Cardioverter‐Defibrillator Therapy (2006) (39)
Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy. (1991) (39)
Immunosuppressive and immunomodulatory treatment for myocarditis. (1996) (38)
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. (2006) (38)
Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. (1986) (38)
Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. (1994) (38)
The use of endomyocardial biopsy in heart failure. (1988) (38)
Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy. (2007) (38)
Outcomes of Elderly Recipients of Implantable Cardioverter Defibrillators (2007) (38)
Heart rate variability in patients with cardiac hypertrophy—Relation to left ventricular mass and etiology (2006) (38)
Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll in patients with acute myocarditis. (1981) (37)
Magnetic Resonance Imaging and Signal‐Averaged Electrocardiography in Patients with Repetitive Monomorphic Ventricular Tachycardia and Otherwise Normal Electrocardiogram (1997) (37)
Immune reactions in infective endocarditis. II. Relevance of circulating immune complexes, serum inhibition factors, lymphocytotoxic reactions, and antibody-dependent cellular cytotoxicity against cardiac target cells. (1983) (37)
Molecular Mechanisms Involved in Atherosclerosis (2002) (37)
Pharmacological modulation of cardiac fibroblast function. (1995) (37)
Quantitative assessment of antilaminin antibodies in myocarditis and perimyocarditis (1987) (36)
Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. (2001) (36)
Immunosuppressive therapy for myocarditis. (1995) (36)
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. (2004) (35)
Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two‐dimensional immunoblotting and N‐terminal sequence analysis (2000) (35)
Course of Symptoms and Spontaneous ECG in Pacemaker Patients: A 5‐Year Follow‐up Study (1988) (34)
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors. (1979) (34)
Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. (2005) (34)
Inverse shift in serum polyunsaturated and monounsaturated fatty acids is associated with adverse dilatation of the heart (2009) (33)
Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. (1993) (33)
The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels. (2006) (33)
Alcohol and rhythm disturbance: the holiday heart syndrome. (1996) (33)
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. (2007) (32)
Immune reactions in infective endocarditis. I. Clinical data and diagnostic relevance of antimyocardial antibodies. (1983) (32)
The sarcolemma as antigen in the secondary immunopathogenesis of myopericarditis (1987) (32)
Treatment of experimental murine Coxsackie B3 myocarditis. (1991) (31)
How Many Patients with Dilated Cardiomyopathy May Potentially Benefit from Cardiac Resynchronization Therapy? (2003) (31)
Humoral immune reactions in uremic pericarditis. (1983) (31)
Cardiac imaging in rheumatic diseases. (2006) (30)
[Alcohol and myocarditis]. (1996) (30)
Dilated Cardiomyopathies as a Cause of Congestive Heart Failure (2002) (29)
Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies. (1991) (29)
Lethal heart failure caused by aluminium phosphide poisoning (2001) (29)
Pericardioscopy--a new diagnostic tool in inflammatory diseases of the pericardium. (1991) (29)
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy (2012) (29)
Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy (2000) (28)
Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. (2002) (28)
Pathophysiology of Cardiac Inflammation: Molecular Mechanisms (2002) (28)
New Directions in Diagnosis and Treatment of Pericardial Disease A Project of the Taskforce on Pericardial Disease of the World Heart Federation (2000) (28)
Cytokines in Pericardial Effusion of Patients with Inflammatory Pericardial Disease (2012) (28)
Management of Patients with Suspected (Peri-)Myocarditis and Inflammatory Dilated Cardiomyopathy (2006) (27)
Non‐compaction cardiomyopathy in an adult with hereditary spherocytosis (2007) (27)
Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury (2004) (27)
Sudden Cardiac Death in Dilated Cardiomyopathy – Therapeutic Options (2002) (27)
Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19. (2005) (27)
[Hypertension and alcohol: central and peripheral mechanisms]. (1996) (27)
Update 2001¶Myokarditis – Kardiomyopathie (2001) (26)
Influence of Pacing Mode and Rate on Peripheral Levels of Atrial Natriuretic Peptide (ANP) (1989) (26)
Dietary linolenic acid-mediated increase in vascular prostacyclin formation (1996) (26)
Parvovirus B19 genome in endomyocardial biopsy specimen. (2004) (26)
A new method to assess ventricular wall stress in patients with heart failure and its relation to heart rate variability. (2010) (26)
Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria (2008) (26)
Integrated Biomarkers in Cardiomyopathies (2007) (26)
Orcadian Variation and Onset Mechanisms of Ventricular Tachyarrhythmias in Patients with Coronary Disease Versus Idiopathic Dilated Cardiomyopathy (2000) (26)
[Classification of the cardiomyopathies]. (2008) (25)
Genetics of Human Hypertension (2003) (24)
Extracellular matrix and cardiac interstitium: restriction is not a restricted phenomenon. (1995) (24)
TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy. (2005) (24)
Intrapericardial Treatment of Autoreactive Myocarditis with Triamcinolon Successful Administration in Patients with Minimal Pericardial Effusion (2000) (24)
Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative (2013) (23)
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency". (2012) (22)
Lipids and Lipoproteins in Women (2005) (22)
Immunological basis of the cardiac conduction and rhythm disorders. (2001) (22)
Reverse epidemiology in different stages of heart failure. (2015) (22)
Radiotelemetric characterization of overweight-associated rises in blood pressure and heart rate. (1999) (22)
Magnetic Resonance Imaging in Pericardial Diseases (2006) (21)
Epicardial halo phenomenon: a guide for pericardiocentesis? (2013) (21)
Significance of accelerated idioventricular rhythm in idiopathic dilated cardiomyopathy. (2000) (21)
Diagnosis and treatment of myocarditis: The role of endomyocardial biopsy (2007) (21)
Arrhythmias in Acute Pericarditis An Endomyocardial Biopsy Study (2000) (21)
Drug withdrawal and rebound hypertension: Differential action of the central antihypertensive drugs moxonidine and clonidine (1996) (20)
Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart (2010) (20)
Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. (2007) (20)
Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. (2008) (20)
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. (2012) (20)
Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis. (1992) (20)
[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited]. (2009) (20)
SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS? (2020) (20)
Cardiac sarcoidosis: cytokine patterns in the course of the disease. (2009) (19)
Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. (2008) (19)
Trypomastigotes and amastigotes of Trypanosoma cruzi induce apoptosis and STAT3 activation in cardiomyocytes in vitro (2013) (19)
Quantification of antimyosin antibodies in experimental myocarditis by a new solid phase fluorometric assay. (1983) (19)
Immunological cellular regulator and effector mechanisms in myocarditis. (1985) (19)
Diabetic cardiomyopathy: ongoing controversies in 2012 (2012) (19)
Percutaneous Therapy in Pericardial Diseases. (2017) (18)
Directions in antihypertensive treatment--our future from the past. (1995) (18)
Molecular Basis of Obesity and the Risk for Cardiovascular Disease (2006) (18)
Fatty acid oxidation inhibition with PPARα activation (FOXIB/PPARα) for normalizing gene expression in heart failure? (2005) (18)
[The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction]. (1995) (18)
Cardiac Rhythm and Conduction Disturbances: What is the Role of Autoimmune Mechanisms? (2000) (18)
Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy (2010) (18)
Managing a complication after direct stenting: removal of a maldeployed stent with rotational atherectomy (2005) (18)
Varicella myocarditis in an adult (2001) (18)
Intrapericardial procedures for cardiac regeneration by stem cells (2010) (18)
Circadian variation and onset mechanisms of ventricular tachyarrhythmias in patients with coronary disease versus idiopathic dilated cardiomyopathy. (2000) (18)
Schedule-induced psychological stress and molecular structures of cardiomyocytes. (1997) (18)
Indications for angiography subsequent to coronary artery bypass grafting. (2005) (17)
Plasmodium falciparum glycosylphosphatidylinositol induces limited apoptosis in liver and spleen mouse tissue (2007) (17)
Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994. (1996) (17)
Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. (1993) (17)
Prognostic Value of Heart Rate Variability Analysis in Patients with Carcinoid Syndrome (2001) (17)
Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment. (2007) (17)
Transthyretin Leu 68 in a form of cardiac amyloidosis (1991) (17)
HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis† (2009) (17)
Antimyolemmal antibodies in myocarditis in children (1987) (17)
Immunology of cardiac tumors. (1990) (17)
[Endothelial dysfunction--assessment of current status and approaches to therapy]. (1999) (17)
Diagnosis of primary cardiac lymphoma by endomyocardial biopsy. (2001) (17)
Surface antigens of adult heart cells and their use in diagnosis. (1985) (17)
Invasive electrophysiological evaluation of patients with sleep apnoea‐associated ventricular asystole—methods and preliminary results (1995) (17)
Familial inflammatory dilated cardiomyopathy (2006) (17)
Isolated Cardiac Sarcoidosis Associated with the Expression of a Splice Variant Coding for a Truncated BTNL2 Protein (2007) (16)
Giant left atrial mass in an asymptomatic patient (2004) (16)
Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischaemic, reperfused porcine hearts. (1995) (16)
Vascular Endothelial Growth Factor in Malignant and Benign Pericardial Effusion (2012) (16)
Increased production of HDL ApoA-I in homozygous familial defective ApoB-100. (2000) (16)
Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies? (1991) (16)
Clinical and Prognostic Effect of a Positive Granulocyte Scan in Infective Endocarditis (1993) (16)
Echocardiographic Findings Mimicking Type A Aortic Dissection (2006) (16)
Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. (2020) (16)
Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy. (2003) (16)
Flexible Percutaneous Pericardioscopy: Inherent Drawbacks and Recent Advances (2000) (15)
Papillary muscle injury after blunt chest trauma. (1997) (15)
111In-labelled granulocytes in inflammatory heart diseases (1987) (15)
Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level". (2006) (15)
[Accelerated idioventricular rhythm]. (1994) (15)
Increased nuclear proto-oncogene expression in hypertrophic cardiomyopathy. (1993) (15)
Endomyocardial biopsy in infants and children: Experience in 60 patients (2005) (15)
Association of right ventricular dysfunction and Cheyne–Stokes respiration in patients with chronic heart failure (2003) (14)
Prediction of Major Arrhythmic Events and Sudden Cardiac Death in Dilated Cardiomyopathy The Marburg Cardiomyopathy Study Design and Description of Baseline Clinical Characteristics (2000) (14)
Focus on Anti-Inflammatory and Antiarrhythmogenic Effects of Long-Chain Omega-3 Fatty Acids (2004) (14)
Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis. (1995) (14)
[Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation]. (1998) (14)
Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis (1980) (14)
Does CMV infection play a role in myocarditis? New aspects from in-situ hybridization. (1991) (14)
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. (2006) (13)
The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research. (2009) (13)
Arrhythmia Risk Prediction in Idiopathic Dilated Cardiomyopathy Based on Heart Rate Variability and Baroreflex Sensitivity (2005) (13)
Inflammatory dilated cardiomyopathy (2020) (13)
Sleep‐Disordered Breathing in Recipients of Implantable Defibrillators (2009) (13)
Circulating immune complexes in perimyocarditis and infective endocarditis (1987) (13)
Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine. (1997) (13)
Assessment and relevance of ventricular wall stress in heart failure. (2008) (13)
The vascular endothelium as target of humoral auto-reactivity in myocarditis and rejection. (1989) (13)
Detection of anti-hsp70 immunoglobulin G antibodies indicates better outcome in coronary artery bypass grafting patients suffering from severe preoperative angina. (2004) (13)
Suspected inflammatory cardiomyopathy (2015) (13)
Alcohol ablation of pericardial cysts under pericardioscopical control (2013) (12)
Cardiocytolysis by Sera of Patients Suffering from Acute Perimyocarditis (1984) (12)
Invasive techniques--from diagnosis to treatment. (2006) (12)
Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure? (2005) (12)
Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy. (2013) (12)
Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure (2012) (12)
Experimental murine myocarditis after immunization with cardiac membranous proteins (1987) (12)
Comparison of Circulating Levels of Interleukin-6 and Tumor Necrosis Factor-Alpha in Hypertrophic Cardiomyopathy and in Idiopathic Dilated Cardiomyopathy (2004) (12)
Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. (2012) (12)
Mitochondrial DNA Deletions in Cardiomyopathies (2000) (12)
N-3 polyunsaturated fatty acids and statins in heart failure (2009) (12)
Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure (2010) (12)
In vitro Simulation of Therapeutic Plasmatic Fibrinolysis (2003) (12)
Myasthenia gravis: Overlap with ‘polyendocrine’ autoimmunity (1983) (12)
Development of a saphenous vein coronary artery bypass graft pseudoaneurysm. (2004) (12)
Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation (1999) (11)
Impaired myocyte function in vitro incubated with sera from patients with myocarditis. (1991) (11)
Cardiac sarcoidosis—clinical and immunoserologic studies (1987) (11)
[Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems]. (1994) (11)
Control of cardiomyocyte gene expression as drug target (2004) (11)
Genotype‐specific effects on left ventricular function in parvovirus B19‐positive patients with dilated cardiomyopathy (2011) (11)
T suppressor cell activity in (peri)myocarditis and infective endocarditis (1987) (11)
Characterization of relevant membrane antigens by two-dimensional immunoblot and n-terminal sequence analysis in patients with myocarditis. (1995) (11)
[Endomyocardial biopsy in myocarditis]. (2000) (10)
Detection of Viral and Bacterial Protein in Endomyocardial Biopsies of Patients with Inflammatory Heart Muscle Disease? (2000) (10)
Depression of Heart Rate Variability in Patients with Increased Ventricular Wall Stress (2009) (10)
Acute Heart Failure—Basic Pathomechanism and New Drug Targets (2006) (10)
Antibodies cross-reactive to streptococci in infective endocarditis (1987) (10)
[Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system]. (2006) (10)
Abdominal Fat and Sympathetic Overactivity (2003) (10)
Why does atherosclerosis occur where it occurs? (2005) (10)
Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. (2005) (10)
Monitoring of Plasmin and Plasminogen Activator Activity in Blood of Patients under Fibrinolytic Treatment by Reteplase (2006) (10)
Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis (2005) (10)
[Prevention of atrial arrhythmias by pacing]. (2001) (10)
Humoral and cellular immune reactions to the myocardium in myocarditis. (1992) (9)
Molecular signatures and the study of gene expression profiles in inflammatory heart diseases (2012) (9)
[Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?]. (1998) (9)
[Value of old and new electrocardiography criteria for differential diagnosis between ventricular tachycardia and supraventricular tachycardia with bundle branch block]. (1996) (9)
Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block (2012) (9)
Acute and Recurrent Pericarditis: Still Idiopathic? (2017) (9)
[Pregnancy and cardiomyopathies]. (2003) (8)
Herz Abdominal Fat and Sympathetic Overactivity From Calorie Intake to Postmenopausal Hypertension (2003) (8)
Failure of omega-3 fatty acids in atrial fibrillation? No deficiency of highly unsaturated fatty acids in the absence of heart failure. (2011) (8)
Value of immunohistological and immunoserological monitoring in cardiac transplantation (1987) (8)
De novo expression of MHC class I and class II antigens on endomyocardial biopsies from patients with inflammatory heart disease and rejection following heart transplantation. (1993) (8)
Humoral and cellular immune response in human myocarditis and dilated cardiomyopathy. (1988) (8)
Autoreactive immune mechanisms in infective endocarditis (1987) (8)
Inflammatory cardiomyopathy. (2006) (8)
Importance of Humoral and Cellular Immunological Parameters for the Pathogenesis of Viral Myocarditis (1988) (8)
Management of pericardial effusion the role of echocardiography in establishing the indications and the selection of the approach for drainage. (2005) (8)
Apolipoprotein A-IV in the fed and fasting states. (2004) (8)
Immunohistological investigations in suspected cardiac sarcoidosis (1987) (8)
Evaluation of the presence of selected viral and bacterial nucleic acids in pericardial samples from dogs with or without idiopathic pericardial effusion. (2009) (8)
[Etiology, diagnosis, management, and treatment of myocarditis. Position paper from the ESC Working Group on Myocardial and Pericardial Diseases]. (2013) (8)
The heart in internal diseases. (2010) (8)
Different profile of antioxidative capacity results in pulmonary dysfunction and amplified inflammatory response After CABG surgery. (2007) (8)
Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy (2015) (8)
[Pericardioscopy--a new window to the heart in inflammatory heart diseases]. (1992) (7)
[Indium-111 or Tc-99m-HMPAO marked granulocytes as specific markers of florid stage endocarditis--results comparing clinical, histological and scintigraphic findings in 30 patients with suspected endocarditis]. (1992) (7)
Humoral and Cell-Mediated Immunity: Pathogenetic Mechanisms in Dilated Cardiomyopathy (1990) (7)
Exercise and sports in cardiac patients and athletes at risk (2015) (7)
[New possibilities of diagnostics and therapy of pericarditis]. (2008) (7)
Right Ventricular Cardiac Myxoma (2005) (7)
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs (2012) (7)
Biomarkers in Inflammatory and Noninflammatory Cardiomyopathy (2009) (7)
Heart rate variability in carcinoid heart disease. (1999) (7)
[Women and autoimmune diseases with cardiovascular manifestations]. (2005) (7)
Four years of experience in endomyocardial biopsy —An immunohistologic approach (2005) (7)
Effect of leukotrienes on isolated vital cardiac cells—an in vitro model of cardiocytotoxic mediators in inflammation? (1987) (7)
Humoral immune response to cardiac conducting tissue (2004) (7)
Management of Pericardial Effusion (2005) (7)
[Humoral immunologic effector mechanisms in perimyocarditis]. (1984) (7)
Coronary artery spasm induced by 5-fluorouracil (2005) (7)
How cardiac cells die--necrosis, oncosis and apoptosis. (1999) (7)
COVID-19—What we know and what we need to know: There are more questions than answers (2020) (7)
[Arterial hypertension and metabolic syndrome]. (2003) (6)
Elevation of the Pacing Threshold: A Side Effect in a Patient with Pacemaker Undergoing Therapy with Doxorubicin and Vincristine (1999) (6)
Lectin binding sites of the sarcolemma and the surrounding interstitial tissue (1987) (6)
443 Relation of B‐type natriuretic peptide to left ventricular wall stress in patients with dilated cardiomyopathy assessed by cardiac magnetic resonance imaging (2006) (6)
[The heart in cases of viral, bacterial and parasitic infections]. (2007) (6)
Control of apoptosis of cardiovascular fibroblasts: A novel drug target (1999) (6)
[Transmyocardial laser revascularization--limits and possibilities]. (1996) (6)
Value and limitations of transesophageal echocardiography in infective endocarditis. (1993) (6)
Effusive-constrictive pericarditis: current perspectives (2018) (6)
Cellular immune mechanisms in myocarditis (2012) (6)
Sensitivity and Specificity of Transesophageal Echocardiography in the Diagnosis of Vegetations and Abscesses in Infective Endocarditis (1989) (6)
[ Update 2001. Myocarditis--cardiomyopathy]. (2001) (6)
Simplified implantation of single-lead pectoral cardioverter defibrillators using device-based testing. (1998) (6)
Guidelines on the Diagnosis and Management of Pericardial Diseases Full Text The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Task Force members , (2004) (6)
[Angina pectoris in extracoronary diseases]. (1999) (5)
[Eosinophilic endomyocarditis post partum or pregnancy-related cardiomyopathy]. (1994) (5)
Functional Determination of Plasminin Arginine-stabilized Plasma (2005) (5)
[Heart transplantation in myocardial sarcoidosis. Studies on the explanted heart]. (1999) (5)
Percutaneous Balloon Pericardiotomy (2011) (5)
Marked Improvement in Left Ventricular Function and Significant Reverse Left Ventricular Remodeling within 3 Months of Cardiac Resynchronization Therapy in Patients with Dilated Cardiomyopathy (2005) (5)
[Etiology of pericardial effusion following radiation therapy of Hodgkin's disease]. (1981) (5)
[Myocardial fibrosis: a cardiopathophysiologic Janus head]. (2006) (5)
[Löffler endocarditis fibroplastica with simultaneous infectious endocarditis]. (1994) (5)
912-39 Interactions Between Handy Phones and Pacemaker Function in Patients with Permanent Pacemakers (1995) (5)
Anticardiac Antibodies in Patients with Chronic Pericardial Effusion (2016) (5)
Rate Responsive Pacing — Initial Experience with the QT(TX/Quintech) and Biorate Pacemakers (1985) (5)
[Progress or regress or both? ESC guidelines on pericardial diseases 2015]. (2015) (5)
The need for European Registries in inherited cardiomyopathies. (2002) (5)
[Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease]. (1995) (5)
Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy. (2007) (5)
Separation of large mammalian ventricular myosin differing in ATPase activity. (2007) (5)
[Changes in atrial natriuretic peptide in patients with lung embolism and obstructive respiratory tract disease]. (1990) (5)
Experimental myocarditis in rabbits—cellular effector mechanisms (1987) (5)
Restenosis after Percutaneous Coronary Interventions and Infection (2000) (5)
Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy. (2013) (5)
Early occurrence of septic pericarditis after Nissen fundoplication. (2003) (5)
Cardiac natriuretic peptide hormones during artificial cardiac pacemaker stimulation and left heart catheterization (1992) (5)
Abstract 1616: Intermediate Dose of Pentaglobin Eradicates Effectively Inflammation in Parvo B19 and Adenovirus Positive Myocarditis (2007) (5)
A New Motion Responsive Pacemaker: First Clinical Experience with an Acceleration Sensor Pacemaker (1992) (5)
Rickettsial perimyocarditis—A follow-up study (2005) (5)
Detection of cytomegalovirus genome by in situ hybridization in paraffin embedded endomyocardial biopsy specimens of viral myocarditis. (1994) (5)
HSPA1B polymorphism in familial forms of inflammatory dilated cardiomyopathy. (2009) (5)
[Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy]. (1999) (5)
[Validation of indirect myocardial parameters of oxygen consumption in patients with normal and pathologically changed ventricular function]. (1989) (4)
Diagnostic and Pathogenic Relevance of Antimyocardial Antibodies and Circulating Immune Complexes in Perimyocarditis and Congestive Cardiomyopathy (1983) (4)
Treatment of cardiovascular diseases in cancer patients (2011) (4)
Underestimation of Stroke Volume (SVI) and Cardiac Index (CI) by TM-Echocardiography during Ventricular Pacing (1983) (4)
[Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention]. (1998) (4)
[Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis]. (2006) (4)
Enrichment of vital adult cardiac muscle cells by continuous silica sol gradient centrifugation (1981) (4)
Images in cardiovascular medicine. Phenotype of infiltrating T lymphocytes in cardiac sarcoidosis. (2002) (4)
Autoimmunity in dilated cardiomyopathy (1996) (4)
Echocardiography: future developments. What is diastole and how to assess it? Impaired left ventricular systolic function. (2011) (4)
Humoral Immune Response in Viral Myocarditis (2003) (4)
Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients. (1993) (4)
[Effect of nifedipine and nitroglycerin on epicardial vessels in coronary heart disease]. (2008) (4)
[Immunoserologic and immunohistologic studies of myocarditis and pericarditis]. (1995) (4)
Pericardial diseases in the era of imaging, biomarkers and molecular diagnosis (2013) (4)
[Premedication visits. Economizing at the cost of the patient?]. (2004) (4)
[Noninvasive methods in the diagnosis of macro- and microangiopathy of peripherial and carotid arteries]. (2004) (4)
[Indications for transmyocardial laser therapy]. (1996) (4)
Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion. (2005) (4)
Local cardiac responses--alternative methods of control. (1991) (4)
Strategies to Optimize CAD Prevention in Modern Cardiology The “Marburg CAD Prevention Project” (2000) (4)
Acute severe thrombocytopenia after c7E3 Fab (abciximab) therapy in a patient with unstable angina and stenting of the right coronary artery. Occurrence of subacute stent thrombosis and safe readministration of the GPIIb/IIIa inhibitor tirofiban (2000) (4)
Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. (1998) (4)
Monitoring of Functional Plasminogen in the Blood of Patients on Fibrinolytics (2009) (4)
[Clinical aspects of infectious endocarditis]. (1989) (4)
[Preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. The 2009 ESC guidelines]. (2010) (4)
Effect of bisoprolol on cardiac performance in coronary heart disease (2004) (4)
[Significance of matrix metalloproteinases in cardiovascular diseases]. (2000) (4)
[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure]. (2002) (4)
[Clinical pathway "Acute Coronary Syndrome"]. (2006) (3)
[The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?]. (2014) (3)
772 Ventricular wall stress in heart failure (2007) (3)
Preoperative and perioperative management of patients with pericardial diseases. (2011) (3)
Left ventricular haemodynamics in murine viral myocarditis. (1995) (3)
[Diagnostics and therapy of pericarditis and pericardial effusion]. (2014) (3)
CD83+ dendritic cells in inflammatory infiltrates of Churg-Strauss myocarditis. (2003) (3)
Bidirectional ventricular tachycardia due to digitalis intoxication (2005) (3)
[Significance of immunologic effector mechanisms in infectious endocarditis]. (1983) (3)
[Tumor markers in the assessment of malignant and benign pericardial effusion]. (2011) (3)
[Endomyocardial biopsy in childhood--experiences in 60 pediatric patients]. (1987) (3)
[Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery]. (2010) (3)
[Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers]. (2009) (3)
Characterization of sucrose-induced changes in cardiac phenotype (2002) (3)
Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy. (1994) (3)
[Fulminant course of falciparum malaria]. (2001) (3)
Innotrac Aio! Second-generation Cardiac Troponin I Assay: Imprecision Profile and Other Key Characteristics for Clinical Use (2004) (3)
Pathophysiological Mechanisms of Parvovirus B19 Infection (2009) (3)
Antiendothelial antibodies in sera of patients with infective endocarditis (2001) (3)
[The heart in viral infections]. (2010) (3)
[Cell death in inflammatory heart muscle diseases--apoptosis or necrosis?]. (1999) (3)
[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]. (1999) (3)
[Cytomegalovirus associated diseases of the heart]. (1992) (3)
Left Ventricular Function During VVI and DVI Pacing at Different Rates as Assessed by M-Mode and Two-Dimensional Echocardiography, Gated Single Photon Emission Computerized Tomography (GASPECT) and Thermodilution (1985) (3)
[Secondary immunopathogenesis of cardiac diseases]. (1984) (3)
Cardiac involvement in chronic polyarthritis and ankylosing spondylitis—an echocardiographic and immunological study (1987) (3)
Prevention of recurrent ventricular fibrillation by ventricular rate stabilization. (2000) (3)
[LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis]. (2003) (3)
[A paradigm change in German academic medicine. Merger and privatization as exemplified with the university hospitals in Marburg and Giessen]. (2005) (3)
Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT 1 vs. PPARalpha Effects of Etomoxir (2003) (3)
[Dilated cardiomyopathy and myocarditis. Current diagnostic requirements and therapeutic possibilities]. (2002) (3)
Long-term survival with acquired ventricular septal defect after myocardial infarction. (2004) (3)
Anticardiac antibodies in hypertrophic cardiomyopathy as a marker of severity. (1992) (3)
Abstract 2950: The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) - Intermediate Analysis of Immunosuppressive Therapy (2006) (3)
Differential diagnosis of pericardial effusion after stem cell transplantation in acute myeloic leukemia (2011) (2)
Image of the Month (2004) (2)
SPONTANEOUS RESOLUTION OF MYOCARDITIS-DATA FROM THE PLACEBO COHORT OF ESETCID (2012) (2)
P-167 Rationale, design and end-points of a clinical study on biventricular pacing for atrioventricular block in left ventricular dysfunction to prevent cardiac desynchronisation — The biopace study (2003) (2)
Abstract 15036: Resolution Of Inflammation Determines Short- And Longterm Prognosis In Myocarditis - data From Esetcid (2011) (2)
Clinical significance of ventricular late potentials in idiopathic dilated cardiomyopathy — A prospective study in 120 patients (1996) (2)
Angiography, CT and MR imaging of a high vena cava inferior interruption in a patient with Hirschsprung disease. (2001) (2)
[Functional genomics of pressure-loaded cardiomyocytes: etomoxir in heart failure?]. (2002) (2)
[Aortic and mitral valve endocarditis after infection of the pacemaker pocket]. (1994) (2)
Coxsackie B3 Myocarditis: Genetic Aspects of Different Immunopathogenic Mechanisms in BALB/c and DBA/2 Mice. Antigenic Specificity of Heart-Reactive Antibodies in DBA/2 Mice (1988) (2)
Immunological parameters in patients with congestive cardiomyopathy (2005) (2)
Control of cardiomyocyte gene expression as drug target. (2000) (2)
[Retrospective studies and prospects of therapy for hypertension]. (1995) (2)
[Beta blockers in therapy of chronic heart failure]. (2002) (2)
[Artificial bradycardias due to tape-running problems of old long-term ECG records]. (1998) (2)
PREVALENCE OF DIFFERENT ETIOLOGIES IN DILATED CARDIOMYOPATHY (2010) (2)
Economic burden of chronic heart failure with preserved vs. reduced ejection fraction – an analysis from the German Competence Network Heart Failure (2013) (2)
Asymptomatic Bland–White–Garland syndrome for 5 decades (2013) (2)
Control of Gene Expression by Catecholamines and the Renin-Angiotensin System (2012) (2)
Cardiomyopathies : Classification, and Treatment (2012) (2)
[Transmyocardial laser revascularization and rehabilitation]. (1997) (2)
[Classification, genetic predisposition and risk factors for the development of cardiomyopathies]. (2008) (2)
Predictive Value of QT Dispersion for Ventricular Tachyarrhythmias in Patients with Implantable Cardioverter Defibrillator (1996) (2)
Cardiovascular benefits of omega-3 polyunsaturated fatty acids (2006) (2)
[Women and pericardial neoplastic manifestations of the heart and pericardium]. (2005) (2)
Enfermedades del pericardio (2008) (2)
Acute effect of calcium channel blockers on adriamycin exposed isolated adult cardiocytes (1985) (2)
Anti-viral and anti-myocyte antibodies in experimental myocarditis (2004) (2)
970-5 Echocardiographic Assessment of Left Ventricular Contractility During Prolonged Head-up Tilt in Patients with Neurally Mediated Syncope (1995) (2)
[Metabolism and the hypertrophied heart of the elderly]. (2005) (2)
Cardiovascular disease in cancer patients… only the tip of the iceberg? (2011) (2)
[Fever and lung abscesses in anorexia nervosa after infusion therapy]. (1994) (2)
[Transmyocardial laser revascularization in stable and unstable angina pectoris]. (1997) (2)
[Excessive hyperchylomicronemia--a rare cause of acute retrosternal and epigastric pain in pregnancy]. (2003) (2)
Chapter 56 Myocarditis, cardiac tamponade, and pericarditis (2010) (2)
[Coronary heart disease as inflammatory disease of the vascular bed? Etiology, sequela or misconception?]. (1998) (2)
A Possible New Transthyretin Genetic Variant in a Family with Cardiac Amyloidosis (1991) (2)
361 Depression of cardiac working capacity in dilated cardiomyopathy (2007) (2)
[Significance of aldosterone antagonist therapy]. (2004) (2)
Biomarker and no end to it? (2009) (2)
Arrhythmias in Acute Pericarditis (2000) (2)
[Clinical experiences with 3 different rate-adaptive pacemaker systems]. (1986) (2)
Pericardial thickness and pericardial effusion as echocardiographic markers of acute or past pericardial, perimyocardial and myocardial disease (1987) (2)
Myocarditis and pericarditis--old questions and new answers. (1992) (2)
[Changes in infectious endocarditis]. (1979) (2)
Posttranscriptional Gene Silencing (2009) (1)
Abstract 1614: Sequential Analysis of Immunosuppressive Therapy in Autoreactive Myocarditis - Sequential Analysis from ESETCID (2007) (1)
[Therapy of dilated cardiomyopathies with and without inflammation]. (1998) (1)
Physical Exercise in Patients with Heart Failure Due to Myocarditis and Dilated Cardiomyopathy (2004) (1)
Lethal myocarditis with atrioventricular block and ventricular tachycardia--a case report. (1990) (1)
[Myocardial infarct after adriamycin]. (1984) (1)
Pericardial effusion and non-constrictive diastolic dysfunction in acromegaly (2006) (1)
["Why is it always the heart which suffers from myocardial infarction?" The "Marburg hypothesis" of the pathogenesis of atherosclerosis]. (2010) (1)
Pericardiocentesis in the Absence of Effusion (2011) (1)
Abstract 20154: Intravenous Pentaglobin Eradicates Inflammation and Reduces Viral Load in Parvo B19 and Adenovirus Positive Myocarditis (2010) (1)
Assessment of increased left ventricular wall stress with the volume-based wall stress index – prediction of left ventricular hypertrophy and late gadolinium enhancement in dilative heart failure (2012) (1)
Case reports--classic textbook information or exceptions from the rule? (1994) (1)
EFFECTIVE HYPERIMMUNOGLOBULIN TREATMENT IN CMV-MYOCARDITIS (2016) (1)
Heart failure 2.0 or 0.1? (2018) (1)
PENTAGLOBIN TREATMENT OF PCR-POSITIVE PARVO B19 MYOCARDITIS (2016) (1)
[Humoral and cellular immunity in perimyocarditis and congestive cardiomyopathy]. (1985) (1)
Proteinase inhibitor complexes in cardiogenic and septic shock (1996) (1)
Image of the month. Cardiac arrest due to severe hyperkalemia. (2004) (1)
Are Anti-cardiac Antibodies in Dilated Cardiomyopathy “Natural” Antibodies? (1993) (1)
Carbohydrate-deficient transferrin in patients with alcoholic cardiomyopathy (1998) (1)
State of the art and perspectives in hypertension. (1995) (1)
[Comments on the contribution by M. Stille-Siegener et al. Myocarditis]. (1994) (1)
[Fetal arrhythmias--new immunologic studies and results]. (1993) (1)
[Extracardiac causes of right ventricular insufficiency]. (2004) (1)
[Sport and the Heart - not a simple connection]. (2015) (1)
[Management of cardiovascular diseases]. (2004) (1)
[Diagnosis and treatment of inflammatory heart diseases: role of endomyocardial biopsy]. (2006) (1)
Alcohol and the heart. (2001) (1)
Incidence and Clinical Significance of Ventricular Late Potentials in Idiopathic Dilated Cardiomyopathy Compared to Coronary Artery Disease (1997) (1)
P2902 Feasibility of rescue pericardiocentesis under fluoroscopic guidance (2003) (1)
Patients’ profiles in end stage coronary artery disease (1997) (1)
[Endomyocardial biopsy-guided diagnosis and treatment of inflammatory cardiomyopathies]. (2004) (1)
Prediction of Major Arrhythmic Events and Sudden Cardiac Death in Dilated Cardiomyopathy Marburg Cardiomyopathy Study Design and Description of Baseline (2000) (1)
Comprar Interventional Pericardiology | Maisch, B. | 9783642113345 | Springer (2011) (1)
[The ESC recommendations for COVID-19-no guideline, but a learning guidance]. (2020) (1)
Behind the Curtain of Pericardial Tamponade: Cardiac Hemangioendotheliosarcoma (2009) (1)
Heart failure update (2012) (1)
[Angina pectoris in leiomyoma]. (1998) (1)
Autoreactive mechanisms in infective endocarditis (2004) (1)
[Reversible grade III atrioventricular block in a 35-year-old patient]. (2001) (1)
Lipomatous hypertrophy of the interatrial septum. Diagnosis by cardiac magnetic resonance imaging. (2005) (1)
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis]. (2000) (1)
[Physical activity and sports in heart failure due to myocarditis and dilated cardiomyopathy]. (2004) (1)
Dilated Cardiomyopathies and Congestive Heart Failure (2003) (1)
[Biventricular inflow tract compression by chronic organized hemopericardium in Caplan syndrome]. (1994) (1)
Immunological features in a case of hypereosinophilic syndrome and myocarditis (2005) (1)
Abstract 20072: Intrapericardial Triamcinolone in Radiation Induced and Intrapericardial Cisplatin Treatment in Malignant Pericardial Effusion Prevent Recurrence Effectively (2010) (1)
[Autoimmune diseases of the heart]. (1990) (1)
[Complicated course of Churg-Strauss syndrome with eosinophilic perimyocarditis and pericardial tamponade]. (2004) (1)
726-5 Autoantibodies to Stress Proteins in Dilated Cardiomyopathy and Biopsy Proven Myocarditis (1995) (1)
997-85 Immunosuppressive Treatment in Autoreactive Myocarditis-Results from a Placebo-controlled Trial (1995) (1)
Functional Determination of Plasminogen Activatorin Arginine-stabilized Plasma (2005) (1)
Cardiomyopathies—past, present, future (2020) (0)
Hemolytic transfusion reaction mimicked by occult retroperitoneal bleeding (2013) (0)
Abstract 1884: One-Year Prognosis in Patients with Markedly Reduced Left Ventricular Function: Association with Results of Endomyocardial Biopsy (2006) (0)
[Secondary immunopathogenesis in myocarditis, diseases of the heart muscles and infarct-associated arrhythmia in childhood and adulthood]. (1989) (0)
599 “Gene silencing” of the coxsackievirus‐adenovirus‐receptor leads to a decreased cytolytic effect after a CVB 3 infection in HeLa‐cells (2005) (0)
Intrapericardial Treatment in Pericardial Disease (2011) (0)
In memoriam of Dr. Heinz Rupp: associate editor of the Canadian Journal of Physiology and Pharmacology. (2014) (0)
439 Tenascin‐C expression as a marker for a Coxsackievirus B3 myocarditis (2006) (0)
[Changes in isometric contraction during the relaxation period following rapid extension]. (1972) (0)
[Comparative studies with propranolol, verapamil and atenolol in hypertensive dialysis patients]. (1977) (0)
JS5-2 Treatment of Viral and Autoreactive Inflammatory Cardiomyopathy (2009) (0)
997-83 Improvement of Cardiac Function in Acute Murine Coxsackievirus B 3 Myocarditis by Interferon 2α (1995) (0)
[On guidelines for the treatment management]. (2006) (0)
A device for fixation and manipulation of organic or inorganic tissues (2006) (0)
[Heart and psyche]. (2001) (0)
Pericardial Diseases 2004 (2012) (0)
AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR-Leitlinie 2021 zum Thoraxschmerz (2022) (0)
In vivo vascular modelling of abdominal aorta based on 3D speckle tracking analysis (2012) (0)
European (jß Volume 12 Supplement D Pages 1-205 Pericardioscopy—a New Diagnostic Tool in Inflammatory Diseases of the Pericardium the Role of Pericardiectomy in Pericardial Disorders the Value of Endomyocardial Biopsies in Myocarditis and Dilated Cardiomyopathy Endomyocardial Biopsy Findings in Case (0)
[Sources of interference for cardiac pacemakers. Technical improvements of pacemakers--risks in the medical realm]. (1998) (0)
Adding colchicine to aspirin may prevent recurrence of acute pericarditis. (2006) (0)
[Cardiology on the edge of the right track]. (2009) (0)
Toll-Like Receptors: Potential Targets for Therapeutic Interventions (2009) (0)
BTNL2 Polymorphism and Cardiac Sarcoidosis (2008) (0)
EOSINOPHILIC HEART DISEASE: DIAGNOSIS AND INDIVUALIZED TREATMENT (2010) (0)
significant disadvantage (Journal of Trauma 2003; 54: 967-72) (2003) (0)
The role of antiendothelial antibodies in myocarditis and its sequelae (1992) (0)
LETTERS TO THE EDITOR (1999) (0)
[Differential diagnosis and prognosis of primary and post-myocarditis cardiomyopathy in childhood]. (1988) (0)
[Humoral autoreactivity in cardiac diseases]. (1994) (0)
[Heart failure today: standstill in progress]. (2002) (0)
Demonstration of TGF-β and XIIIα in Endocardial Biopsies of Carcinoid Heart Disease Patients: an Immunofluorescence Study (2011) (0)
Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis) (1998) (0)
[Risk factors for pacemaker disorders]. (1997) (0)
[Guidelines--"to be continued"]. (2010) (0)
Alternative Techniques for Pericardiocentesis (2011) (0)
Retrospective and perspectives in the immunology of cardiac diseases (2004) (0)
Keynote Lecture : Autoantibodies and Cardiomyopathy(Autoimmunity in the Heart,ESC-JCS Joint Symposium (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Cardiomyopathy and myocarditis — A review of new aspects in research in West Germany (2005) (0)
Interventional therapies for pericardial diseases (2018) (0)
Gene Expression of Cardiac Myocytes: A Pharmacologic Target for the Failing Heart? (1996) (0)
Circulating auto-antibodies against the membrane of isolated cardiocyte-lightand electron microscopical study (1987) (0)
Improvement of cardiopulmonary function in carcinoid heart disease by treatment with octreotide (1998) (0)
Asymptomatic Thrombus Formation on Patent Foramen Ovale Occluder 3.5 Months After Implantation (2004) (0)
Diagnostic Value of Pericardial Fluid Analyses (2011) (0)
Echocardiographic Diagnosis of Ischemic Ventricular Septal Defect in a Patient with Acute Myocardial Infarction (2004) (0)
Clinical aspects of endomyocardial biopsy in patients with different forms of myocardial disease (1987) (0)
[Coenzyme Q10 in ischemic heart disease]. (1987) (0)
Anemia with LDH-elevation in a patient with aortic valve replacement. (1994) (0)
4.P.219 Apolipoprotein AIV: Occurrence in plasma after oral and intravenous fat loads (1997) (0)
[Hypertension--only high blood pressure?]. (2003) (0)
[Correlation between cardiac autonomic activity and compromise of left ventricular function in dilated cardiomyopathy]. (2000) (0)
Interventionelle kardiovaskuläre Therapie (2012) (0)
Chapter 26 Pericardiocentesis (2010) (0)
[Humoral immunologic effector mechanisms in perimyocarditis]. (1984) (0)
Linear Lesion Formation by ND:YAG Laser Versus Radiofrequency Energy in Porcine Atria (2000) (0)
Experimental Studies of Humoral and Cellular Immunological Parameters of Viral Heart Disease (1993) (0)
[Heart insufficiency--what is it?]. (2006) (0)
Depression and coronary artery disease: epidemiology and potential mechanisms. (2006) (0)
[Possibilities and limits of outpatient antibiotic therapy of infective endocarditis]. (2001) (0)
[Pregnancy and the heart--a need for institutionalized cooperation]. (2003) (0)
[Guidelines 2015 - old wine in new skins?]. (2015) (0)
[Immune phenomenon following cardiotomy and heart infarct]. (1977) (0)
Abstract 5938: Detection of Cardiac Antibodies in Acute Rheumatic Fever and Rheumatic Heart Disease by Two-Dimensional Western Blot Analysis (2008) (0)
[Differential diagnostic challenge in pericardial effusion]. (1995) (0)
Reply to letter from Josef Finsterer and Claudia Stollberger (2007) (0)
Abstract 2971: Investigation of Endomyocardial Biopsies from 3345 Patients Over 10 Years - A Retrospective Analysis by Immunohistology and Molecular Biology (2006) (0)
Expression of major histocompatibility complex (MHC) antigens in the heart in experimental coxsackie B3 myocarditiS (1991) (0)
Characterization of mouse polycystic kidney disease and receptor for egg jelly gene and protein in heterologous and native system (2006) (0)
Prevalence of unexplaned left heart manifestations in carcinoid heart disease (1998) (0)
[Interventional cardiovascular therapy. Current status 2012]. (2012) (0)
[Guidelines 2014 - a revival of old and new recommendations]. (2014) (0)
[For patients. Acute heart failure syndrome]. (2006) (0)
Intolerance of TEE probe Pulmonary complications Bronchospasm Hypoxia Cardiac complications Nonsustained ventricular tachycardia Transient atrial fibrillation Third-degree atrioventricular block Severe angina pectoris Bleeding complications Minor pharyngeal bleeding (2005) (0)
[ESC guidelines 2017 : What is new and what is of particular importance?] (2017) (0)
Anatomy of the Pericardium Relevant for Pericardial Access, Pericardioscopy, and Intrapericardial Interventions (2011) (0)
Risk of interference between pacemakers and security systems. (1999) (0)
[Alterations in the passive and active performance of cat papillary muscle induced by variation of preload (author's transl)]. (1975) (0)
ANTICARDIAC ANTIBODIES IN ACUTE RHEUMATIC FEVER AND CHRONIC RHEUMATIC HEART DISEASE - ANALYSIS FROM INDIAN AND RUSSIAN PATIENTS (2010) (0)
What do tachycardiomyopathy belong to?: reply (2008) (0)
Colour Doppler echocardiography in patients with neuroendocrine gastrointestinal tumors (NEGT) (1992) (0)
[Silent myocardial ischemia--diagnostic dilemma and challenge]. (1991) (0)
[Reorganization of university clinics--Chirurg (2005) 76:68-70]. (2005) (0)
[Ethics in medicine]. (2014) (0)
Abstract 14714: Impact Of The Differential Diagnosis In Tumor Patients With Neoplastic Or Radiation Induced Pericardial Effusion (2011) (0)
Chairman’s Summary (1996) (0)
[Laboratory diagnosis in preventive cardiology]. (1999) (0)
Dilated Cardiomyopathy – a Syndrome, not a Homogeneous Disease (2007) (0)
806-2 Is sporadic arrhythmogenic right ventricular cardiomyopathy an infectious disease? (2004) (0)
Molecular mechanisms and stem cell therapy. (2002) (0)
[Therapy recommendation--"Viagra and NO donors"]. (1999) (0)
[Pacemaker therapy in sleep apnea syndrome]. (1991) (0)
[Guidelines -- substitute textbook guidelines for daily or limited use?]. (2009) (0)
Measurement of aortic wall strain with 3D speckle tracking (2012) (0)
Lipomatous hypertrophy of the interatrial septum (2005) (0)
EXPERIMENTAL & CLINICAL CARDIOLOGY (2014) (0)
Pericardiosopy: Endoscopic Insight in Pericardial and Epicardial Pathology (2011) (0)
Coxsackie B3 virus infection in C3H severe combined immunodeficient mice shows significant differences in the early stage of disease when compared to immunocompetent C3H mice (1995) (0)
Genetic variability in the bag3 gene (BCL2-associated athanogene 3) in patients with dilated cardiomyopathy (2013) (0)
[Endomyocardial biopsy--helpful in differential diagnosis between myocarditis and dilated cardiomyopathy. A case report]. (1997) (0)
Corrigendum to “A new but frequent mutation of apoB-100—apoB His3543Tyr” [Atherosclerosis 2004;174(1):11–16] (2005) (0)
Epicardial and Pericardial Biopsy (2011) (0)
Alternative Techniques for Pericardiocentesis 5 (0)
Abstract 14672: Blue Light During Pericardioscopy Improves the Diagnostic Yield of Epicardial and Pericardial Biopsy (2011) (0)
991-71 Electrophysiologic Findings in Patients with Obstructive Sleep Apnea Associated Ventricular Asystole (1995) (0)
Pericardial Effusion and Cardiac Tamponade (2011) (0)
[Recurrent ventricular fibrillation after defibrillation in a patient with pacemaker]. (2000) (0)
CAD-Prevention — a perspective (1999) (0)
Statement on matching language to the type of evidence used in describing outcomes data (2013) (0)
1013-115 Familial predisposition for inflammatory cardiomyopathy (2004) (0)
Srce i krvni Sudovi (2013) (0)
PREVALENCE AND PROGNOSTIC IMPACT OF ANEMIA AND RENAL INSUFFICIENCY: RELATION TO HEART FAILURE SEVERITY (2011) (0)
Water-soluable vitamin deficiency. (1997) (0)
[Vasculitis : EULAR/ACR guidelines with respect to the clinical cardiological routine]. (2015) (0)
659 Decreased heart rate variability in patients with increased ventricular wall stress (2008) (0)
Gene symbol: MYBPC3. Disease: Cardiomyopathy, hypertrophic. (2008) (0)
Abstract 3909: Intrapericardial Cisplatin Treatment Prevents Effectively the Recurrence of Neoplastic Pericardial Effusion (2009) (0)
Cardiomyopathies : retrospective and perspective (Professor Tohru Izumi Retirement Symposium : Heart Failure and Myocardial Disease : Message to the Next Generation) (2013) (0)
Pericardial Access and Drainage: Standard Techniques (2011) (0)
Recruiting and Baseline of the HIV-HEART Study: A Prospective, Multicenter Trial to Analyze Cardiac Diseases in HIV-Infected Patients (2010) (0)
1109-133 The role of pericardioscopy and epicardial biopsy in determination of the etiological treatment for chronic pericardial effusions (2004) (0)
Cardiomyopathies: retrospective and perspective (2012) (0)
Comparison of Baroreflex Sensitivity with Age and Indices of Left Ventricular Function in Patients with Dilated Cardiomyopathy (1999) (0)
Omacor® in clinical development: a survey of current trials. (2006) (0)
Frontiers and Emerging Procedures (2011) (0)
[Therapy recommendations for adverse effects of Viagra and nitrates (NO-donors)]. (1998) (0)
[2019 ESC guidelines: consensus in Europe for 25 years]. (2019) (0)
Is endstage heart disease really terminal? (1997) (0)
Change of MHC class 1 expression on human myocytes during immunosuppression (1992) (0)
[Cardiac rehabilitation--more than just for the garden plot?]. (2012) (0)
Abstract 4507: MASTER-DES: The Atherosclerotic Lesion, Not The Stent Type Determines Outcome (2008) (0)
[New aspects of cardiac pacemaker therapy]. (1985) (0)
Vascular endothelial growth factor-1 gene transfer effect of angiogenesis in transmyocardial laser revascularization treated procine myocardium (2004) (0)
[Similar, but not the same: peripheral and coronary vascular disease]. (2004) (0)
THE +49AG POLYMORPHISM IN EXON 1 OF THE CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 IS ASSOCIATED WITH DILATED CARDIOMYOPATHY (2010) (0)
[Lipid lowering therapy for primary prevention of coronary heart disease--pro lipid lowering therapy]. (1998) (0)
145 Cardiac magnetic resonance based assessment of cardiac work by pressure-volume and stress-length relation in patients with dilated cardiomyopathy and aortic valve stenosis (2008) (0)
1087-107 Transforming growth factor beta and factor XIIIa are constituents of the carcinoid heart endocardial layer: A study by confocal laser microscopy (2004) (0)
Dichotomous Effects of Cyclophosphamide in Murine Coxsackievirus B3-Induced Myocarditis (1990) (0)
We-P11:30 Marburg hypothesis of coronary artery disease: A new concept of atherosclerosis in patients with diabetes mellitus (2006) (0)
[Autoantibodies and inhibitory factors in cardiomyopathies]. (1978) (0)
Cytokine Signaling in Tissue Engineering (2009) (0)
[Paradoxic occurrence of symptoms of rheumatic fever after thrombolytic therapy with streptokinase--a case of delayed hypersensitivity?]. (1994) (0)
1075 Assessment and relevance of ventricular wall stress in dilated cardiomyopathy (2008) (0)
Abstract 4042: Epidemiology of Inflammatory and Non-inflammatory Dilated Cardiomyopathy: Initial Assessement From the KNHI Demonstrate Underdiagnosis of Inflammatory and Familial Cardiomyopathy (2009) (0)
Apparatus for tissue and organ manipulation (2003) (0)
[Alterations of cat papillary muscle mechanics induced by changes of preload under variation of physical and chemical parameters (author's transl)]. (1976) (0)
Determinants for Coronary Atherosclerosis Regression. The Marburg Lipid Intervention Trial (1993) (0)
[Joy and sorrow with guidelines 2013]. (2013) (0)
[Heart failure - deliberate diagnosis of various causes or only diagnostic and therapeutic endpoints?]. (2011) (0)
Myocarditis (1990) (0)
Dispersion of repolarization in patients with dilated cardiomyopathy (2000) (0)
[Alcohol and the heart - a never-ending story of the world's oldest drug]. (2016) (0)
[Amiodarone induced pulmonary toxicity]. (2002) (0)
[Effects of lipid lowering measures on coronary perfusion]. (1997) (0)
[Seeking Ariadne's thread in the labyrinth of guidelines]. (2016) (0)
1314 The role of pericardioscopy and epicardial biopsy in determination of the etiological treatment for chronic pericardial effusions (2003) (0)
MUTATIONS IN THE GENE CODING FOR THE M2-MUSCARINIC ACETYLCHOLINE RECEPTOR CHRM2, A POTENTIAL NEW CANDIDATE GENE FOR DILATED CARDIOMYOPATHY (2011) (0)
Pathogenesis, diagnosis and treatment of pericarditis (2010) (0)
[Stroke prophylaxis by closure of a patent foramen ovale: CLOSURE I study]. (2012) (0)
Arrhythmias in biopsy proven acute myocarditis versus acute pericarditis with no evidence of myocarditis in endomyocardial biopsy (2002) (0)
Abstract 14740: Cardiac Magnetic Resonance Imaging Or Endomyocardial Biopsy For The Diagnosis Of Myocarditis And Viral Heart Disease (2011) (0)
Nothing new in heart failure? A current misconception! (2012) (0)
[The 4 R of the ESC guidelines 2018: relevance, redundancy, reality, and relativization]. (2018) (0)
[Treatment paths--freedom or limitation]. (2004) (0)
Radiotelemetric characterization of overweight-associated rises in blood pressure and heart rate. (1999) (0)
[2020 ESC guidelines in the shadow of the COVID-19 pandemic]. (2020) (0)
[Diagnosis of Ebstein's anomaly with transesophageal echocardiography]. (1994) (0)
[Noninvasive diagnosis of major circulatory function]. (1995) (0)
Reply to: Pitfalls in the differentiation between athlete’s heart… (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernhard Maisch?

Bernhard Maisch is affiliated with the following schools:

Bernhard Maisch's Academic­Influence.com Rankings

Why Is Bernhard Maisch Influential?

Bernhard Maisch's Published Works

Published Works

What Schools Are Affiliated With Bernhard Maisch?

Bernhard Maisch's AcademicInfluence.com Rankings